RESEARCH-USE BIOSIMILAR ANTIBODY
Praluzatamab
Antibody-drug conjugate · IgG1
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
TARGETCD166
YAntibody-drug conjugate
CATALOGSC-BS-253
CATALOG NUMBERSC-BS-253
MOLECULAR WEIGHTApprox. 146.9 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116). Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates). Praluzatamab can be used for research of cancers.
Praluzatamab is a recombinant research-use antibody directed against CD166.